166 related articles for article (PubMed ID: 17855185)
1. Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and diabetic foot infections.
Wang S; Cunha BA; Hamid NS; Amato BM; Feuerman M; Malone B
J Chemother; 2007 Aug; 19(4):410-6. PubMed ID: 17855185
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics/pharmacodinamic (PK/PD) evaluation of a short course of oral administration of metronidazole for the management of infections caused by Bacteroides fragilis].
Morales-León F; von Plessing-Rossel C; Villa-Zapata L; Fernández-Rocca P; Sanhueza-Sanhueza C; Bello-Toledo H; Mella-Montecinos S
Rev Chilena Infectol; 2015 Apr; 32(2):135-41. PubMed ID: 26065445
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
5. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
6. Bacteroides fragilis vertebral osteomyelitis: case report and a review of the literature.
Elgouhari H; Othman M; Gerstein WH
South Med J; 2007 May; 100(5):506-11. PubMed ID: 17534088
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole treatment of Bacteroides fragilis infections.
Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
[TBL] [Abstract][Full Text] [Related]
9. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
Wacha H; Warren B; Bassaris H; Nikolaidis P;
Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of diabetic foot infections.
Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Metronidazole in experimental Bacteroides fragilis otitis media.
Thore M; Sjöberg W; Burman LG; Holm SE
Acta Otolaryngol; 1985; 99(1-2):60-6. PubMed ID: 3976396
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin unresponsive anaerobic osteomyelitis treated with oral metronidazole.
Zimmerman J; Silver J; Shapiro M; Friedman G; Melmed RN
Scand J Infect Dis; 1980; 12(1):79-80. PubMed ID: 7367840
[TBL] [Abstract][Full Text] [Related]
16. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
Roy S; Higareda I; Angel-Muller E; Ismail M; Hague C; Adeyi B; Woods GL; Teppler H;
Infect Dis Obstet Gynecol; 2003; 11(1):27-37. PubMed ID: 12839630
[TBL] [Abstract][Full Text] [Related]
17. Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
Teppler H; McCarroll K; Gesser RM; Woods GL
Surg Infect (Larchmt); 2002; 3(4):337-49. PubMed ID: 12697080
[TBL] [Abstract][Full Text] [Related]
18. Systemic prophylaxis with metronidazole (Flagyl) in elective surgery of the colon and rectum.
Bjerkeset T; Digranes A
Surgery; 1980 May; 87(5):560-6. PubMed ID: 7368106
[TBL] [Abstract][Full Text] [Related]
19. Role of postoperative antibiotics after appendectomy in non-perforated appendicitis.
Hussain MI; Alam MK; Al-Qahatani HH; Al-Akeely MH
J Coll Physicians Surg Pak; 2012 Dec; 22(12):756-9. PubMed ID: 23217479
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
